I 'm a big fan of Python for data analysis, but even I get curious about what else is available. R has long been the go-to ...

Intensity Therapeutics’ stock has risen nearly 400% after its oncology candidate showed high overall survival (OS) and ...

APL is fusing its analytic and cutting-edge AI capabilities into a forward-leaning incubator, known as GenWar Lab, that ...

The published manuscript detailed the safety and efficacy results of INT230-6, Intensity’s intratumoral therapy for treating metastatic or refractory cancers. The data showed a 75% disease control ...

The advantage of Python is that you can apply operations to larger datasets with hundreds, even thousands, of data points ...

A systematic review published today in Psychedelics by Mr. James Gattuso and colleagues at the Florey Institute of Neuroscience and Mental Health synthesizes clinical and preclinical evidence on ...

Objectives To evaluate the long-term efficacy of remote ischaemic postconditioning (RIPC) on functional outcomes in patients ...

Data from an exploratory analysis of the pivotal phase 3 MIRASOL trial (NCT04209855) were recently unveiled at the 2025 European Society for Medical Oncology (ESMO) Congress, opening a broader ...

Tonmya demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT studyTreatment was well tolerated ...

CESSA Phase 3 Clinical Trial Results Earn ACG Presidential Poster Distinction Among Nearly 6,000 Abstracts Next-generation Hydrocortisone Acetate (ngHCA™) Suppository Administered with Sephure® Suppos ...